Intocell Company
Intocell is a biotechnology company that develops antibody drug conjugate (ADC) platform technologies.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
Daejeon, Taejon-jikhalsi, South Korea
Founded Date:
2015
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership